Cas no 1237524-82-1 (2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1))
2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) Chemical and Physical Properties
Names and Identifiers
-
- 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1)
- BCP32171
- Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide
- Sodium(3-oxo-3,4-dihydropyrazine-2-carbonyl)amide
- Sodium;(2-oxo-1H-pyrazine-3-carbonyl)azanide
- AKOS037646725
- 1237524-82-1
- sodium (3-oxo-3,4-dihydropyrazin-2-yl)carbonylazanide
- AS-70485
-
- MDL： MFCD22572804
- Inchi： 1S/C5H5N3O2.Na/c6-4(9)3-5(10)8-2-1-7-3;/h1-2H,(H3,6,8,9,10);/q;+1/p-1
- InChI Key： FDKLFFRIKMFDNO-UHFFFAOYSA-M
- SMILES： [Na+].O=C1C(C([NH-])=O)=NC=CN1
Computed Properties
- Exact Mass: 161.02012066g/mol
- Monoisotopic Mass: 161.02012066g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 246
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 59.5?2
Experimental Properties
- Color/Form: NA
- Flash Point: 79.7±24.6 °C
2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) Security Information
- Signal Word：warning
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement： P264+P280+P305+P351+P338+P337+P313
- Safety Instruction： H303+H313+H333
- Storage Condition：Storage at -4 ℃ (6-12weeks), long storage period at -20 ℃ (1-2years), transport at 0 ℃
2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM328272-100mg |
sodium;(2-oxo-1H-pyrazine-3-carbonyl)azanide |
1237524-82-1 | 95%+ | 100mg |
$90 | 2021-08-18 | |
| Chemenu | CM328272-250mg |
sodium;(2-oxo-1H-pyrazine-3-carbonyl)azanide |
1237524-82-1 | 95%+ | 250mg |
$96 | 2021-08-18 | |
| Chemenu | CM328272-1g |
sodium;(2-oxo-1H-pyrazine-3-carbonyl)azanide |
1237524-82-1 | 95%+ | 1g |
$313 | 2021-08-18 | |
| Chemenu | CM328272-5g |
sodium;(2-oxo-1H-pyrazine-3-carbonyl)azanide |
1237524-82-1 | 95%+ | 5g |
$752 | 2021-08-18 | |
| ChemScence | CS-M1514-250mg |
Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide |
1237524-82-1 | ≥98.0% | 250mg |
$17.0 | 2022-04-28 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P64450-1g |
Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide |
1237524-82-1 | 1g |
￥3332.0 | 2021-09-08 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P64450-5g |
Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide |
1237524-82-1 | 5g |
￥10032.0 | 2021-09-08 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | P64450-250mg |
Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide |
1237524-82-1 | 250mg |
￥1162.0 | 2021-09-08 | ||
| ChemScence | CS-M1514-5g |
Sodium (3-oxo-3,4-dihydropyrazine-2-carbonyl)amide |
1237524-82-1 | ≥98.0% | 5g |
$145.0 | 2022-04-28 | |
| eNovation Chemicals LLC | D762121-1g |
2-PyrazinecarboxaMide, 3,4-dihydro-3-oxo-, sodiuM salt (1 |
1237524-82-1 | 97% | 1g |
$65 | 2024-06-06 |
2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) Suppliers
Audited Supplier
2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) Related Literature
-
Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
Additional information on 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1)
Comprehensive Overview of 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) (CAS No. 1237524-82-1)
The compound 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1), identified by its CAS No. 1237524-82-1, is a specialized chemical entity with significant applications in pharmaceutical and biochemical research. This sodium salt derivative of pyrazinecarboxamide has garnered attention due to its unique structural properties and potential utility in drug development. Researchers are increasingly exploring its role as a building block for novel therapeutic agents, particularly in the context of metabolic and inflammatory diseases.
One of the key reasons for the growing interest in 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) is its compatibility with modern drug discovery platforms. Its molecular framework allows for facile modifications, making it a versatile intermediate in synthetic chemistry. Recent studies have highlighted its potential as a precursor for kinase inhibitors, a class of compounds that are pivotal in targeted cancer therapies. This aligns with the current trend in precision medicine, where CAS No. 1237524-82-1 is being evaluated for its efficacy in modulating specific biochemical pathways.
In addition to its pharmaceutical applications, 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) is also being investigated for its role in agrochemical formulations. The compound's stability and solubility profile make it a candidate for developing next-generation crop protection agents. This is particularly relevant given the global push for sustainable agriculture and the need for environmentally friendly alternatives to traditional pesticides.
The synthesis of CAS No. 1237524-82-1 involves a series of well-documented chemical reactions, ensuring high purity and yield. Analytical techniques such as HPLC and NMR spectroscopy are routinely employed to characterize the compound, ensuring compliance with industry standards. Quality control is a critical aspect, especially when the compound is intended for use in regulated environments like clinical trials or agricultural field tests.
From a commercial perspective, the demand for 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) is expected to rise, driven by its multifaceted applications. Suppliers and manufacturers are focusing on scalable production methods to meet the needs of research institutions and industrial partners. The compound's CAS No. 1237524-82-1 is frequently searched in scientific databases, reflecting its relevance in contemporary research.
Safety and handling protocols for 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) are well-established, emphasizing the importance of proper storage and disposal. While the compound is not classified as hazardous under standard regulations, adherence to good laboratory practices is recommended to ensure safe usage. This is particularly important for researchers who are exploring its potential in high-throughput screening assays.
In summary, 2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1) (CAS No. 1237524-82-1) represents a promising chemical entity with broad applicability across multiple industries. Its structural versatility, coupled with its potential therapeutic and agrochemical benefits, positions it as a compound of significant interest. As research continues to uncover new uses for this molecule, its role in advancing science and technology is likely to expand further.
1237524-82-1 (2-Pyrazinecarboxamide, 3,4-dihydro-3-oxo-, sodium salt (1:1)) Related Products
- 19838-07-4(3-methyl-1H-pyrazin-2-one)
- 88394-06-3(Des-(6-Flouro) 6-Methyl Favipiravir)
- 259793-88-9(6-bromo-3-oxo-3,4-dihydropyrazine-2-carboxamide)
- 259793-96-9(Favipiravir)
- 25680-54-0(3-Ethylpyrazin-2(1h)-one)
- 55321-99-8(T-1105)
- 24387-68-6(2(1H)-Pyrazinone,sodium salt (1:1))
- 185949-08-0(2-Pyrazinecarboxamide,3,4-dihydro-N-hydroxy-3-oxo-)
- 81411-78-1(3-oxo-3,4-dihydropyrazine-2-carbonitrile)
- 88394-05-2(2-Pyrazinecarboxamide,3,4-dihydro-5-methyl-3-oxo-)
